Folic acid administration produces an antidepressant-like effect in mice: Evidence for the involvement of the serotonergic and noradrenergic systems

Neuropharmacology

Volumn 54, Issue 2, 2008, Pages 464-473

  Brocardo, Patrícia S ^a   Budni, Josiane ^a   Kaster, Manuella P ^a   Santos, Adair R S ^a   Rodrigues, Ana Lúcia S ^a  

^a FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

Author keywords

Antidepressant; Folic acid; Forced swimming test; Noradrenaline; Serotonin; Tail suspension test

Indexed keywords

ALPHA ADRENERGIC RECEPTOR; FENCLONINE METHYL ESTER; FLUOXETINE; FOLIC ACID; KETANSERIN; N [2 [4 (2 METHOXYPHENYL) 1 PIPERAZINYL]ETHYL] N (2 PYRIDYL)CYCLOHEXANECARBOXAMIDE; PRAZOSIN; SEROTONIN; SEROTONIN 1A RECEPTOR; SEROTONIN 2 RECEPTOR; SEROTONIN RECEPTOR; YOHIMBINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG MECHANISM; DRUG POTENTIATION; FEMALE; FORCED SWIMMING TEST; LOCOMOTION; MALE; NONHUMAN; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RAT; SEROTONINERGIC SYSTEM;

ADRENERGIC ALPHA-ANTAGONISTS; ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSION; FEMALE; FENCLONINE; FLUOXETINE; FOLIC ACID; HINDLIMB SUSPENSION; INJECTIONS, INTRAVENTRICULAR; MALE; MICE; MOTOR ACTIVITY; NOREPINEPHRINE; PRAZOSIN; RECEPTOR, SEROTONIN, 5-HT1A; SEROTONIN; SEROTONIN AGENTS; SEROTONIN UPTAKE INHIBITORS; SWIMMING; YOHIMBINE;

EID: 38349075216     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2007.10.016     Document Type: Article

References (52)

1. Abou-Saleh M.T., and Coppen A. Folic acid and the treatment of depression. Journal of Psychosomatic Research 61 (2006) 285-287
2. Ago Y., Koyama Y., Baba A., and Matsuda T. Regulation by 5-Ht1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex. Neuropharmacology 45 (2003) 1050-1056
3. Ali A., Pillai K.K., and Pal S.N. Effects of folic acid and lamotrigine therapy in some rodent models of epilepsy and behaviour. Journal of Pharmacology 55 (2003) 387-391
4. Alpert J.E., Mischoulon D., Rubenstein G.E., Bottonari K., Nierenberg A.A., and Fava M. Folinic acid (Leucovorin) as an adjunctive treatment for SSRI-refractory depression. Annals of Clinical Psychiatry 14 (2002) 33-38
5. Bailey L.B., and Gregory III J.F. Folate metabolism and requirements. Journal of Nutrution 129 (1999) 779-782
6. Borsini F., and Meli A. Is the forced swimming test a suitable model for revealing antidepressant activity?. Psychopharmacology 94 (1988) 147-160
7. Botez M.I., Young S.N., Bachevalier J., and Gauthier S. Effect of folic acid and vitamin B12 deficiencies on 5-hydroxyindoleacetic acid in human cerebrospinal fluid. Annals of Neurology 12 (1982) 479-484
8. Bottiglieri T. Homocysteine and folate metabolism in depression. Progress in Neuro-Psychopharmacology & Biological Psychiatry 29 (2005) 1103-1112
9. Coppen A., and Bailey J. Enhancement of the antidepressant action of fluoxetine by folic acid: a randomised, placebo controlled trial. Journal of Affective Disorders 60 (2000) 121-130
10. Coppen A., and Bolander-Gouaille C. Treatment of depression: time to consider folic acid and vitamin B12. Journal of Psychopharmacology 19 (2005) 59-65
11. Cousins M.S., and Seiden L.S. The serotonin-1A receptor antagonist WAY-100635 modifies fluoxetine's antidepressant-like profile on the differential reinforcement of low rates 72-s schedule in rats. Psychopharmacology 148 (2000) 438-442
12. Cryan J.F., and Lucki I. Antidepressant-like behavioral effects mediated by 5- hydroxytryptamine 2C receptors. The Journal of Pharmacology and Experimental Therapeutics 295 (2000) 1120-1126
13. Cryan J.F., Valentino R.J., and Lucki I. Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neuroscience and Biobehavioral Reviews 29 (2005) 547-569
14. Eckeli A.L., Dach F., and Rodrigues A.L.S. Acute treatments with GMP produce antidepressant-like effects in mice. NeuroReport 11 (2000) 1839-1843
15. Elhwuegi A.S. Central monoamines and their role in major depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 28 (2004) 435-451
16. Fava M., Borus J.S., Alpert J.E., Nierenberg A.A., Rosenbaum J.F., and Bottiglieri T. Folate, B12, and homocysteine in major depressive disorder. The American Journal of Psychiatry 154 (1997) 426-428
17. Gevaerd M.S., and Takahashi R.N. Involvement of dopamine receptors on locomotor stimulation and sensitization elicited by the interaction of ethanol and mazindol in mice. Pharmacology Biochemistry and Behavior 63 (1999) 395-399
18. Glowinski J., and Axelrod J. Inhibition of uptake of tritiated-noradrenaline in the intact rat brain by imipramine and structurally related compounds. Nature 204 (1964) 1318-1319
19. Gorman J.M., and Sullivan G. Noradrenergic approaches to antidepressant therapy. Journal of Clinical Psychiatry 61 Suppl. 1 (2000) 13-16
20. Gospe S.M.J., Gietzen D.W., Summers P.J., Lunetta J.M., Miller J.W., Selhub J., Ellis W.G., and Clifford A.J. Behavioral and neurochemical changes in folate-deficient mice. Physiology & Behavior 58 (1995) 935-941
21. 1A receptors-G protein interactions in brain following chronic antidepressant administration. Neuropsychopharmacology 26 (2002) 565-573
22. 1A receptors in the antidepressant-like effect of adenosine in the mouse forced swimming test. Brain Research Bulletin 67 (2005) 53-61
23. Kaster M.P., Budni J., Binfaré R.W., Santos A.R.S., and Rodrigues A.L.S. The inhibition of different types of potassium channels underlies the antidepressant-like effect of adenosine in the mouse forced swimming test. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31 (2007) 690-696
24. Kreiss J.D.S., and Lucki I. Effects of acute and repeated administration of antidepressant drugs on extracellular levels of 5-hydroxytryptamine measured in vivo. Journal Pharmacology and Experimental Therapeutics 254 (1995) 866-876
25. Levitt A.J., Wesson V.A., and Joffe R.T. Impact of suppression of thyroxine on folate status during acute antidepressant therapy. Psychiatry Research 79 (1998) 123-129
26. 1A receptors. British Journal of Pharmacology 108 (1993) 669-677
27. Maas J.W. Biogenic amines and depression. Biochemical and pharmacological separation of two types of depression. Archives of General Psychiatry 32 (1975) 1357-1361
28. Machado D.G., Kaster M.P., Binfaré R.W., Dias M., Santos A.R.S., Pizzolatti M.G., Brighente I.M.C., and Rodrigues A.L.S. Antidepressant-like effect of the extract from leaves of Schinus molle L. in mice: evidence for the involvement of the monoaminergic system. Progress in Neuro-Psychopharmacology & Biological Psychiatry 31 (2007) 421-428
29. Mattson M.P., and Shea T.B. Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders. Trends in Neurosciences 26 (2003) 137-146
30. Millan M.J. The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review. European Journal of Pharmacology 500 (2004) 371-384
31. Morris M.S., Fava M., Jacques P.F., Selhub J., and Rosenberg I.H. Depression and folate status in the US population. Psychotherapy and Psychosomatics 72 (2003) 80-87
32. 1B receptors in the mediation of behavior in the forced swim test in mice. Neuropsychopharmacology 24 (2001) 391-398
33. Page M.E., Detke M.J., Dalvi A., Kirby L.G., and Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology 147 (1999) 162-167
34. Papakostas G.I., Petersen T., Lebowitz B.D., Mischoulon D., Ryan J.L., Nierenberg A.A., Bottiglieri T., Alpert J.E., Rosenbaum J.F., and Fava M. The relationship between serum folate, vitamin B12, and homocysteine levels in major depressive disorder and the timing of improvement with fluoxetine. International Journal of Neuropsychopharmacology 8 (2005) 523-528
35. Paul R.T.P., Mcdonnell A.P., and Kelly C.B. Folic acid: neurochemistry, metabolism and relationship to depression. Human Psychopharmacology 19 (2004) 477-488
36. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Archives Internationales de Pharmacodynamie et de Thérapie 229 (1977) 327-336
37. Ramaekers V. Cerebral folate deficiency. Developmental Medicine & Child Neurology 46 (2004) 843-851
38. Ramos M.I., Allen L.H., Haan M.N., Green R., and Miller J.W. Plasma folate concentrations are associated with depressive symptoms in elderly Latina women despite folic acid fortification. The American Journal of Clinical Nutrition 80 (2004) 1024-1028
39. 3 receptors in activity of antidepressants in the mouse forced swimming test. European Journal of Pharmacology 325 (1997) 129-135
40. 1B receptors in antidepressant drug actions in the mouse forced swimming test. European Journal of Pharmacology 318 (1996) 213-220
41. Redrobe J.P., Bourin M., Colombel M.C., and Baker G.B. Dose-dependent noradrenergic and serotonergic properties of venlafaxine in animal models indicative of antidepressant activity. Psychopharmacology 138 (1998) 1-8
42. Reynolds E.H. Benefits and risks of folic acid to the nervous system. Journal of Neurology, Neurosurgery, and Psychiatry 72 (2002) 567-571
43. Richelson E. Pharmacology of antidepressants. Mayo Clinic Proceedings 76 (2001) 511-527
44. Richelson E., and Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain synaptosomes: most antidepressants selectively block norepinephrine uptake. European Journal Pharmacology 104 (1984) 277-286
45. 1A antagonist WAY-100635 selectively potentiates the presynaptic effects of serotonergic antidepressants in rat brain. Neuroscience Letters 219 (1996) 123-126
46. Ross S.B., and Renyi A.L. Inhibition of the uptake of tritiated 5-hydroxytryptamine in brain tissue. European Journal of Pharmacology 7 (1969) 270-277
47. Schildkraut J.J. The catecholamine hypothesis of affective disorders: a review of supporting evidence. American Journal of Psychiatry 122 (1965) 509-522
48. Steru L., Chermat R., Thierry B., and Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 85 (1985) 367-370
49. Taylor M.J., Carney S., Geddes J., and Goodwin G. Folate for depressive disorders. Journal of Psychopharmacology 18 (2004) 251-256
50. Wagner C. Biochemical Role of Folate in Cellular Metabolism (1995), Marcel Dekker, New York
51. Zomkowski A.D.E., Rosa A.O., Lin J., Santos A.R.S., Calixto J.B., and Rodrigues A.L.S. Evidence for serotonin receptor subtypes involvement in agmatine antidepressant like-effect in the mouse forced swimming test. Brain Research 1023 (2004) 253-263
52. Zuideveld K.P., Treijtel N., Maas H.J., Gubbens-Stibbe J.M., Peletier L.A., Van der Graaf P.H., and Danhof M. A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia. Journal of Pharmacology and Experimental Therapeutics 300 (2002) 330-338